Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis: An exploratory investigation

International Journal of MS Care

Volumn 15, Issue 1, 2013, Pages 21-26

  Finlayson, Marcia ^a,b   Preissner, Katharine ^a   Cho, Chi ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880641066     PISSN: 15372073     EISSN: None     Source Type: Journal    
DOI: 10.7224/1537-2073.2012-011     Document Type: Article

References (30)

1. Centers for Disease Control. Chronic diseases and health promotion. Centers for Disease Control website. 2010. http://www.cdc.gov/ chronicdisease/overview/index.htm. Accessed March 23, 2011.
2. Dowrick C, Dixon-Woods M, Holman H, Weinman J. What is chronic illness? Chronic Illn. 2005;1:1-6.
3. Kantarci OH, Weinshenker BG. Natural history of multiple sclerosis. Neurol Clin. 2005;23:17-38.
4. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GAM. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661-674.
5. Marrie RA, Horwitz R, Cutter G, Tyry T. Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand. 2012;125: 180-186.
6. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler. 2009;15:385-392.
7. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009;72:117-124.
8. Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol. 2010;9:820-828.
9. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler. 2008;14:1091-1098.
10. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10: 430-439.
11. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
12. Finlayson M, Preissner K, Cho C, Plow M. Randomized trial of a teleconference-delivered fatigue management program for people with multiple sclerosis. Mult Scler J. 2011;17:1130-1140.
13. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-1123.
14. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734-739.
15. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis. 1994;18(suppl 1):S79-S83.
16. Finlayson M. Pilot study of an energy conservation education program delivered by telephone conference call to people with multiple sclerosis. NeuroRehabilitation. 2005;20:267-277.
17. Chakroborty H, Gu H. A Mixed Model Approach for Intent-to-Treat Analysis in Longitudinal Clinical Trials with Missing Values. Research Triangle Park, NC: RTI Press, Inc; 2009.
18. Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1.
19. Ryan P, Sawin K. The individual and family self-management theory: background and perspectives on context process and outcomes. Nurs Outlook. 2009;57:217-225.
20. Sevick M, Trauth J, Ling B, et al. Patients with complex chronic diseases: perspectives on supporting self-management. J Gen Intern Med. 2007;22:438-444.
21. Noël P, Parchman M, Williams J, et al. The challenges of multimorbidity from the patient perspective. J Gen Intern Med. 2007;22:419-424.
22. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler. 2003;9:219-227.
23. Jason LA, Evans M, Brown M, Porter N. What is fatigue? pathological and nonpathological fatigue. PM&R 2010;2:327-331.
24. Matuska K, Mathiowetz V, Finlayson M. Use and perceived effectiveness of energy conservation strategies for managing multiple sclerosis fatigue. Am J Occup Ther. 2007;61:62-69.
25. Kos D, Duportail M, D'hooghe MB, Nagels G, Kerckhofs E. Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler. 2007;13:996-1003.
26. Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler. 2005;11:592-601.
27. Sauter C, Zebenholzer K, Hisakawa J, Zeitlhofer J, Vass K. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients. Mult Scler. 2008;14:500-505.
28. Tamir O, Wainstein J, Abadi-Korek I, Horowitz E, Shemer J. The patient-perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care. Diabetes Metab Res Rev. 2012;28:246-251.
29. Yasuda YL. Rheumatoid arthritis, osteoarthritis and fibromyalgia. In: Radomski MV, Trombly Latham CA, eds. Occupational Therapy for Physical Dysfunction. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:1214-1243.
30. Orchanian DP. Rheumatoid arthritis. In: Achison BJ, Dirette DK, eds. Conditions in Occupational Therapy: Effect on Occupational Performance. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:275-310.